UC San Diego and one of the world's biggest health care companies announced plans Friday to collaborate on research and educational programs, according to a published report.
Johnson & Johnson and UCSD hope to turn lab work into new treatments faster, the San Diego Union-Tribune reported. University officials said Thursday that a memorandum of understanding has been signed by the two parties and a formal agreement will be inked soon, the report said.
"This collaboration will further accelerate our efforts at UC San Diego to translate the exciting discoveries being made every day in our laboratories into improved diagnostic and treatment technologies that benefit all patients," said David Brenner, M.D., vice chancellor for health sciences.
The first project they will collaborate on will involve a $75,000 study of a new drug developed by Johnson & Johnson to treat heart failure, the paper reported.
